Skip to content

Evotec

US · EVO #3659 by market cap Listed 2021
1.32 -0.13 -8.97%
Periodic snapshot; not a real-time feed. · 2026-11-20 17:47

About Evotec

Evotec SE is a life science company, which engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the Shared R&D and Just–Evotec Biologics segments. The Shared R&D segment includes drug discovery and development services and solutions. The Just–Evotec Biologics segment provides services related to designing, discovering, developing, and manufacturing of modern biotherapeutics. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, Charles Weissmann, and Nobel Laureate on December 8, 1993 and is headquartered in Hamburg, Germany.

Founded
1998
CEO
Mr. Christian Wojczewski, PhD
Employees
4,553
Headquarters
Hamburg, Hamburg, Germany
Fiscal year end
12-31
Website
evotec.com

Company profile

Exchange
US
Symbol
EVO
Market-cap rank
#3659
Listing date
2021-11-04
Market cap
469.11M
Float cap
388.02M
Shares out
355.39M
Float shares
293.95M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 17:47:50 · For reference only, not investment advice and not tailored to your situation.

Evotec discussion 0 comments

Add a comment